At the age of 39, this female patient presented with suggestive malignancy in her right breast, accompanied by enlargement of the right axillary lymph nodes. The initiation of ECCT as Treatment for breast Cancer with enlargement on May 22, 2012, marked a pivotal moment in her treatment journey.
39岁时，这位女性患者出现了右乳腺可能恶性的征兆，伴随着右腋窝淋巴结肿大。2012年5月22日开始的ECCT疗法标志着她治疗旅程的一个关键时刻。Initially, the patient's condition appeared normal, albeit with a mass in the right breast suspected to be encephalitis. ECCT intervention proved instrumental in targeting and eliminating cancer cells, facilitating their absorption into the body and subsequent excretion. This therapeutic process resulted in a noticeable reduction in the size of the lump and a flattening of the affected breast.
最初，患者的情况看似正常，但右乳腺存在一个被怀疑为脑炎的肿块。ECCT干预在定位和消灭癌细胞方面发挥了重要作用，促使这些细胞被身体吸收并随后排出。这种治疗过程导致肿块大小显著减小，受影响的乳房变平。
Early observations following the commencement of ECCT revealed a softening of the breast tissue, coinciding with the development of redness on the skin surface. Over time, there was a progressive decrease in the size of the lump within the right breast, accompanied by a corresponding reduction in breast volume.
在ECCT开始后的早期观察中，发现乳房组织变软，与此同时皮肤表面出现红斑。随着时间的推移，右乳腺内肿块的大小逐渐减小，伴随着乳房体积的相应减少。Evaluation of the patient's progress through subsequent assessments revealed a significant transition in the activity levels of the malignancy, with scans indicating a shift from a malignant to a benign status. Notably, the reddened skin overlying the breast underwent a transformation, gradually turning black and dry. As the treatment journey progressed, the patient's final condition remained stable.
通过随后的评估，评估患者的进展显示出肿瘤活动水平的显著转变，扫描结果显示从恶性到良性的转变。值得注意的是，覆盖在乳房上的红肿皮肤经历了一种转变，逐渐变黑变干。随着治疗旅程的进行，患者的最终状况保持稳定。
留言